中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2008年
10期
774-776
,共3页
李宇%周岩冰%李玉军%刘相萍%孙琦%李世宽%徐克锋
李宇%週巖冰%李玉軍%劉相萍%孫琦%李世寬%徐剋鋒
리우%주암빙%리옥군%류상평%손기%리세관%서극봉
胃肿瘤%肿瘤转移%病理学,临床%淋巴结
胃腫瘤%腫瘤轉移%病理學,臨床%淋巴結
위종류%종류전이%병이학,림상%림파결
Stomach neoplasms%Neoplasm metastasis%Pathology,clincal%Lymph nodes
目的 检测胃下部癌患者常规病理阴性第11P组淋巴结微转移的情况,分析淋巴结微转移与临床病理因素的关系.方法 应用连续切片法和端粒酶重复扩增-ELISA方法 检测43例胃下部癌常规病理阴性的43枚第11P组淋巴结,结合临床病理资料进行统计学分析. 结果 本组43例胃下部癌患者常规病理阴性第11P组淋巴结经连续切片法检出有4例4枚淋巴结发生微转移,微转移发生率为9%;应用端粒酶重复扩增-ELISA法检测微转移发生率为44%,其中包括应用连续切片法检测出有微转移的4枚淋巴结.端粒酶重复扩增-ELISA法微转移检出率明显高于连续切片法(x 2 =13.07,P<0.05).胃下部癌第11P组淋巴结微转移与原发肿瘤大小(x 2 =8.488,P<0.05)、浸润深度(x 2 =6.473,P<0.05)及临床分期(x 2 =12.022,P<0.05)有关,与患者年龄、性别、大体分型、组织分化程度尤关.结论 胃下部癌常规病理阴性第11P组淋巴结中存在较高的微转移发生率,其微转移发生率与原发肿瘤大小、浸润深度及临床分期有关.
目的 檢測胃下部癌患者常規病理陰性第11P組淋巴結微轉移的情況,分析淋巴結微轉移與臨床病理因素的關繫.方法 應用連續切片法和耑粒酶重複擴增-ELISA方法 檢測43例胃下部癌常規病理陰性的43枚第11P組淋巴結,結閤臨床病理資料進行統計學分析. 結果 本組43例胃下部癌患者常規病理陰性第11P組淋巴結經連續切片法檢齣有4例4枚淋巴結髮生微轉移,微轉移髮生率為9%;應用耑粒酶重複擴增-ELISA法檢測微轉移髮生率為44%,其中包括應用連續切片法檢測齣有微轉移的4枚淋巴結.耑粒酶重複擴增-ELISA法微轉移檢齣率明顯高于連續切片法(x 2 =13.07,P<0.05).胃下部癌第11P組淋巴結微轉移與原髮腫瘤大小(x 2 =8.488,P<0.05)、浸潤深度(x 2 =6.473,P<0.05)及臨床分期(x 2 =12.022,P<0.05)有關,與患者年齡、性彆、大體分型、組織分化程度尤關.結論 胃下部癌常規病理陰性第11P組淋巴結中存在較高的微轉移髮生率,其微轉移髮生率與原髮腫瘤大小、浸潤深度及臨床分期有關.
목적 검측위하부암환자상규병리음성제11P조림파결미전이적정황,분석림파결미전이여림상병리인소적관계.방법 응용련속절편법화단립매중복확증-ELISA방법 검측43례위하부암상규병리음성적43매제11P조림파결,결합림상병리자료진행통계학분석. 결과 본조43례위하부암환자상규병리음성제11P조림파결경련속절편법검출유4례4매림파결발생미전이,미전이발생솔위9%;응용단립매중복확증-ELISA법검측미전이발생솔위44%,기중포괄응용련속절편법검측출유미전이적4매림파결.단립매중복확증-ELISA법미전이검출솔명현고우련속절편법(x 2 =13.07,P<0.05).위하부암제11P조림파결미전이여원발종류대소(x 2 =8.488,P<0.05)、침윤심도(x 2 =6.473,P<0.05)급림상분기(x 2 =12.022,P<0.05)유관,여환자년령、성별、대체분형、조직분화정도우관.결론 위하부암상규병리음성제11P조림파결중존재교고적미전이발생솔,기미전이발생솔여원발종류대소、침윤심도급림상분기유관.
Objective To evaluate the status of lymph node micrometastases in "non-metastatic" No11P lymph nodes as judged by conventional pathology in the lower third of gastric cancer. Methods In this study 43 No11P lymph nodes harvested from 43 patients which was histologically free of metastasis were examined by consecutive sections and TRAP( telomeric repeat amplification protocol)-ELISA (enzyme linked immunosorbent assay). The data were statistically analyzed according to the clinicopathological features of the patients. Results Micrometastasis was discovered in 4 lymph nodes from 4 patients by consecutive sections. The micrometastatic rate of the conventional pathologic non-metastatic No11P lymph nodes was 9%. The micrometastatic rate of the conventional pathologic non-metastasis No11P lymph nodes detected by TRAP-ELISA was 44%, including 4 lymph nodes observed by consecutive sections It revealed that lymph nodes micrometastases were correlated with the size of the tumor( x2 = 8. 488, P < 0. 05 )、and tumor stage (x2 = 12. 022,P < 0. 05 ). It also showed that the micrometastatic rate increased proportionally to tumor infiltration depth(x2 =6. 473, P <0. 05), not correlated with patients' demographic features, general type and histological differentiation of the tumor. Conclusions There was a high rate of micrometastasis in No11P lymph nodes. This lymph nodes micrometastasis was correlated with the size of the tumor, invasion depth of primary tumor and patients' clinical stage.